Cetirizine hydrochloride is a second-generation histamine H1 antagonist that is effective in treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Cetirizine does not cause drowsiness or anticholinergic side effects opposed to conventional antihistamines. Cetirizine is available in various forms such as regular and chewable tablets, capsules, and solutions.
Market Dynamics
Increasing prevalence of allergic conditions in children and adult population is major factor driving growth of the cetirizine hydrochloride market. According to the National Health Interview Survey (NHIS), 2014, around 8.4% of children under the age of 18 suffered from hay fever, 10% from respiratory allergies, 5.4% from food allergies, and 11.6% from skin allergies in the U.S. Furthermore, allergic conjunctivitis imposes economic and social burden on the affected population, thereby increasing the adoption of efficient treatment to curb the increasing healthcare costs. According to the Department of Ophthalmology and Visual Sciences, University of Wisconsin, 2013, an estimated 6 million people are affected by bacterial conjunctivitis, annually in the U.S. The total expenditure in treatment of the disease was reported around US $377 million to US$ 857 million, annually.
Key features of the study:
- This report provides in-depth analysis of the cetirizine hydrochloride market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by leading players
- It profiles leading players in the global cetirizine hydrochloride market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include, Johnson and Johnson, Mylan, Inc., Nicox S.A., Strides Shasun, Apotex, Inc., Teva UK Limited, Aurobindo Pharma Limited, Jubilant Life Sciences, Tris Pharma, Inc., and Cipla Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- The global cetirizine hydrochloride market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the cetirizine hydrochloride market
Detailed Segmentation:
- Global Cetirizine Hydrochloride Market, By Dosage Form:
- Global Cetirizine Hydrochloride Market, By Age Group:
- Global Cetirizine Hydrochloride Market, By Application:
- Allergic Rhinitis
- Allergic Conjunctivitis
- Eczema
- Others
- Global Cetirizine Hydrochloride Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Cetirizine Hydrochloride Market, By Geography:
- North America
- By Dosage Form:
- By Age Group:
- By Application:
- Allergic Rhinitis
- Allergic Conjunctivitis
- Eczema
- Others
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country:
- Latin America
- By Dosage Form:
- By Age Group:
- By Application:
- Allergic Rhinitis
- Allergic Conjunctivitis
- Eczema
- Others
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Dosage Form:
- By Age Group:
- By Application:
- Allergic Rhinitis
- Allergic Conjunctivitis
- Eczema
- Others
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Dosage Form:
- By Age Group:
- By Application:
- Allergic Rhinitis
- Allergic Conjunctivitis
- Eczema
- Others
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country:
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Dosage Form:
- By Age Group:
- By Application:
- Allergic Rhinitis
- Allergic Conjunctivitis
- Eczema
- Others
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Dosage Form:
- By Age Group:
- By Application:
- Allergic Rhinitis
- Allergic Conjunctivitis
- Eczema
- Others
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country:
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Johnson and Johnson*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments
- Market Strategies
- Mylan, Inc.
- Nicox S.A.
- Strides Shasun
- Apotex, Inc.
- Teva UK Limited
- Aurobindo Pharma Limited
- Jubiliant Life Sciences
- Tris Pharma, Inc.
- Cipla Ltd.
“*” marked represents similar segmentation in other categories in the respective section.
